
Opinion|Videos|January 2, 2025
Evolving Treatment Paradigms in Ph+ ALL
Dr. Bijal Shah explores the recent advancements and shifts in treatment strategies for Ph+ ALL, driven by innovations in targeted therapies and evolving clinical practices
Advertisement
- How has the treatment approach for Ph+ ALL evolved in recent years?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Single-Dose Oral Antibiotic Zoliflodacin Treats Drug-Resistant Gonorrhea
3
T-DXd Regimens Show Better Tolerability, Manageable Safety in High-Risk, HER2-Positive Early Breast Cancer
4
Evaluation of Albumin Platelet Product for Fibrosis Detection in MASLD
5













































